BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 9866488)

  • 1. Silicone gel breast implant adverse event reports to the Food and Drug Administration, 1984-1995.
    Brown SL; Parmentier CM; Woo EK; Vishnuvajjala RL; Headrick ML
    Public Health Rep; 1998; 113(6):535-43. PubMed ID: 9847926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MedWatch: the FDA medical products reporting program.
    Rheinstein PH
    Am Fam Physician; 1993 Sep; 48(4):636-8. PubMed ID: 8379493
    [No Abstract]   [Full Text] [Related]  

  • 4. Surgical stapler-associated fatalities and adverse events reported to the Food and Drug Administration.
    Brown SL; Woo EK
    J Am Coll Surg; 2004 Sep; 199(3):374-81. PubMed ID: 15325606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
    Fleuranceau-Morel P
    Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. US Food and Drug Administration: adverse event reporting.
    Graham AA
    CRNA; 1998 Nov; 9(4):135-8. PubMed ID: 9866488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving patient care by reporting problems with medical devices.
    White GG; Weick-Brady MD; Goldman SA; Gross TP; Kennedy DL; Lucas BS; Merritt K; Naschinski C
    CRNA; 1998 Nov; 9(4):139-56. PubMed ID: 9866489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of niacin in the US Food and Drug Administration adverse event reporting database.
    Alsheikh-Ali AA; Karas RH
    Am J Cardiol; 2008 Apr; 101(8A):9B-13B. PubMed ID: 18375244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-marketing surveillance and adverse drug reactions.
    Shani S
    Isr Med Assoc J; 1999 Oct; 1(2):117-9. PubMed ID: 10731310
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidural conduction device fractures and complications of retained fragments.
    Fischer R
    AANA J; 2008 Feb; 76(1):37-40. PubMed ID: 18323318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infusion pump adverse events: experience from medical device reports.
    Brown SL; Morrison AE; Parmentier CM; Woo EK; Vishnuvajjala RL
    J Intraven Nurs; 1997; 20(1):41-9. PubMed ID: 9060364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmarketing surveillance and reporting of adverse drug events.
    Baer RK
    S D J Med; 2004 Jan; 57(1):13-4. PubMed ID: 14964975
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.